Start / PharmaTalkRadio / 5th annual immuno oncology 360%cb%9a 12 minutes of what to expect

PharmaTalkRadio

5th Annual Immuno-Oncology 360˚: 12 minutes of What to Expect

13 min • 19 november 2018

IO360° brings together science, clinical and business under one roof to accelerate treatments to fight a wider range of cancers. This brief podcast gives you an overview on what you can expect at IO360°. The three-day summit features 10 plenary sessions with over 80 speakers and includes ten plus hours of networking. There will be over 450 attendees. Key benefits: Access to KOLs driving the sciencePartnership opportunities with all stakeholders in Immuno-OncologyPresentations on the latest data affecting the science, clinical and business advancements in Immuno-Oncology IO360° is chaired by Dr Andrew Baum, Citi along with Dr Axel Hoos, GlaxoSmithKline and Dr James Gulley, National Cancer Institute. Learn more information about IO360° at www.io360summit.com Take 10% off the regitration fee with code RADIO

Senaste avsnitt

Directors' Talk DPHARM 2025 - AI Sessions; Part III

25 juli | 6 min

Innovations in Manufacturing to Make CAR-T More Accessible and Affordable

25 juli | 20 min

Achieving Oral Delivery of Peptides through Formulation and Molecule Design Approaches

25 juli | 29 min

Catalyzing Change: The Business Imperative of Patient-Centric Drug Development

21 juli | 26 min

How Emerging Biopharma CMOs Can Better Partner with Patient Organizations

21 juli | 32 min

Podcastbild

00:00 -00:00

Podcastbild

00:00 -00:00